DK1510580T3 - Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf - Google Patents
Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse herafInfo
- Publication number
- DK1510580T3 DK1510580T3 DK04077562T DK04077562T DK1510580T3 DK 1510580 T3 DK1510580 T3 DK 1510580T3 DK 04077562 T DK04077562 T DK 04077562T DK 04077562 T DK04077562 T DK 04077562T DK 1510580 T3 DK1510580 T3 DK 1510580T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- obtaining
- methods
- polypeptides
- truncated
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 208000005176 Hepatitis C Diseases 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28295994A | 1994-07-29 | 1994-07-29 | |
US50660895A | 1995-07-25 | 1995-07-25 | |
PCT/US1995/010035 WO1996004301A2 (en) | 1994-07-29 | 1995-07-26 | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1510580T3 true DK1510580T3 (da) | 2009-02-16 |
Family
ID=26961777
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95928779T DK0773957T3 (da) | 1994-07-29 | 1995-07-26 | Udskilt hepatitis C-virus-E1/E2-kompleks opnået fra C-terminalt trunkerede E1- og E2-polypeptider |
DK04077562T DK1510580T3 (da) | 1994-07-29 | 1995-07-26 | Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95928779T DK0773957T3 (da) | 1994-07-29 | 1995-07-26 | Udskilt hepatitis C-virus-E1/E2-kompleks opnået fra C-terminalt trunkerede E1- og E2-polypeptider |
Country Status (12)
Country | Link |
---|---|
US (1) | US6326171B1 (da) |
EP (2) | EP1510580B1 (da) |
JP (4) | JP3793571B2 (da) |
AT (2) | ATE298764T1 (da) |
CA (1) | CA2195312A1 (da) |
DE (2) | DE69535899D1 (da) |
DK (2) | DK0773957T3 (da) |
ES (2) | ES2316920T3 (da) |
IL (3) | IL114775A (da) |
MX (1) | MX9700677A (da) |
MY (1) | MY121563A (da) |
PT (1) | PT1510580E (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998050556A2 (en) * | 1997-05-06 | 1998-11-12 | Chiron Corporation | Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
EP1233782B1 (en) * | 1999-12-01 | 2008-11-05 | Novartis Vaccines and Diagnostics, Inc. | Eliciting hcv-specific antibodies |
US7439042B2 (en) * | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
WO2006044923A2 (en) * | 2004-10-18 | 2006-04-27 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis c infection |
WO2009131681A2 (en) * | 2008-04-22 | 2009-10-29 | Rutgers, The State University | Hcv e2 construct compositions and methods |
US9758794B2 (en) | 2008-04-22 | 2017-09-12 | Rutgers, The State University Of New Jersey | HCV E2 construct compositions and methods |
EP2331125A4 (en) | 2008-09-19 | 2013-03-27 | Globeimmune Inc | IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
CN105621806B (zh) * | 2016-01-22 | 2018-10-30 | 南京贝克特环保科技有限公司 | 一种快速处理餐厨垃圾废水的生物聚沉氧化工艺 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1074422C (zh) | 1987-11-18 | 2001-11-07 | 希龙股份有限公司 | 制备含有hcv表位的分离多肽的方法 |
UA50829C2 (uk) | 1989-03-17 | 2002-11-15 | Чірон Корпорейшн | Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл |
JP2656996B2 (ja) | 1989-05-18 | 1997-09-24 | カイロン コーポレイション | Nanbvの診断用薬 |
JPH06501845A (ja) | 1990-08-02 | 1994-03-03 | カイロン コーポレイション | バキュロウイルス―昆虫細胞発現システムを用いたヒトcmv糖タンパク質―hの発現 |
RO115446B1 (ro) | 1990-11-08 | 2000-02-28 | Chiron Corp | Procedeu de obtinere a asialoglicoproteinelor purificate provenind de la virusul hepatitei c |
US6274148B1 (en) * | 1990-11-08 | 2001-08-14 | Chiron Corporation | Hepatitis C virus asialoglycoproteins |
DE69526636T3 (de) | 1994-07-29 | 2006-11-23 | Innogenetics N.V. | Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung |
-
1995
- 1995-07-26 JP JP50681496A patent/JP3793571B2/ja not_active Expired - Fee Related
- 1995-07-26 EP EP04077562A patent/EP1510580B1/en not_active Expired - Lifetime
- 1995-07-26 EP EP95928779A patent/EP0773957B1/en not_active Expired - Lifetime
- 1995-07-26 AT AT95928779T patent/ATE298764T1/de active
- 1995-07-26 DK DK95928779T patent/DK0773957T3/da active
- 1995-07-26 DE DE69535899T patent/DE69535899D1/de not_active Expired - Lifetime
- 1995-07-26 ES ES04077562T patent/ES2316920T3/es not_active Expired - Lifetime
- 1995-07-26 CA CA002195312A patent/CA2195312A1/en not_active Abandoned
- 1995-07-26 DE DE69534296T patent/DE69534296T2/de not_active Expired - Lifetime
- 1995-07-26 ES ES95928779T patent/ES2244965T3/es not_active Expired - Lifetime
- 1995-07-26 MX MX9700677A patent/MX9700677A/es not_active Application Discontinuation
- 1995-07-26 PT PT04077562T patent/PT1510580E/pt unknown
- 1995-07-26 AT AT04077562T patent/ATE417109T1/de active
- 1995-07-26 DK DK04077562T patent/DK1510580T3/da active
- 1995-07-28 IL IL114775A patent/IL114775A/en not_active IP Right Cessation
- 1995-07-29 MY MYPI95002179A patent/MY121563A/en unknown
-
1999
- 1999-10-08 US US09/415,582 patent/US6326171B1/en not_active Expired - Lifetime
-
2000
- 2000-08-14 IL IL13784000A patent/IL137840A0/xx unknown
-
2005
- 2005-05-12 JP JP2005140416A patent/JP2005290010A/ja not_active Withdrawn
-
2006
- 2006-10-04 JP JP2006273393A patent/JP4298735B2/ja not_active Expired - Fee Related
-
2007
- 2007-06-21 JP JP2007164420A patent/JP2007291126A/ja not_active Withdrawn
- 2007-08-08 IL IL185119A patent/IL185119A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE417109T1 (de) | 2008-12-15 |
DK0773957T3 (da) | 2005-10-24 |
JP2007291126A (ja) | 2007-11-08 |
MY121563A (en) | 2006-02-28 |
JP2007006901A (ja) | 2007-01-18 |
JP4298735B2 (ja) | 2009-07-22 |
DE69535899D1 (de) | 2009-01-22 |
JP2005290010A (ja) | 2005-10-20 |
EP0773957B1 (en) | 2005-06-29 |
IL185119A0 (en) | 2007-12-03 |
EP1510580A3 (en) | 2005-06-22 |
JP3793571B2 (ja) | 2006-07-05 |
MX9700677A (es) | 1997-04-30 |
JP2002515005A (ja) | 2002-05-21 |
EP0773957A2 (en) | 1997-05-21 |
PT1510580E (pt) | 2009-02-18 |
EP1510580B1 (en) | 2008-12-10 |
ES2244965T3 (es) | 2005-12-16 |
CA2195312A1 (en) | 1996-02-15 |
US6326171B1 (en) | 2001-12-04 |
IL137840A0 (en) | 2001-10-31 |
IL114775A (en) | 2006-12-10 |
DE69534296D1 (de) | 2005-08-18 |
DE69534296T2 (de) | 2006-04-27 |
ES2316920T3 (es) | 2009-04-16 |
ATE298764T1 (de) | 2005-07-15 |
EP1510580A2 (en) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996004301A3 (en) | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same | |
IL185119A0 (en) | Method of producing a secreted hcv polypeptide | |
NO870668D0 (no) | Fremgangsmaate for gjenvinning av mikrobielt fremstilt rekombinant. | |
DE69432475D1 (de) | Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis | |
DK2202308T3 (da) | Fremgangsmåder og sammensætninger til manipulation af polypeptider | |
NO904562D0 (no) | Positivt virkende fotoresist og fremgangsmaate til fremstilling derav. | |
DK3687A (da) | Polypeptider og fremgangsmaade til fremstilling deraf | |
DE3888921D1 (de) | Polypeptide. | |
DK1017715T3 (da) | Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse | |
DE3579148D1 (de) | Polypeptid und polypeptidzusammensetzung. | |
DK295188A (da) | Fibronectinbindende protein og fremgangsmaade til fremstilling heraf | |
ATE223481T1 (de) | Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator | |
ATE360695T1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
FI841288A0 (fi) | Rekombinant-dna-kod foer uttryckning av polypeptid. | |
DK34990D0 (da) | Fremgangsmaade og aggregat til fokuseret ventilation | |
ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
ATE291080T1 (de) | Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden | |
NO873216L (no) | Rekombinante htlv-iii-proteiner og anvendelse derav. | |
NO970113L (no) | Kollagenbindende protein eller polypeptid | |
DE69124561D1 (de) | Methode zur reinigung von polypeptiden | |
NO890174D0 (no) | Rekombinante interleukin-1alfa-polypeptider. | |
NO961086D0 (no) | Nye proteiner/polypeptider og kotransfeksjonsplasmider og levende rekombinante bærere for disse | |
DE59108261D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
NO891485D0 (no) | Fremgangsmaate til fremstilling av 22 kd-sgh-protein og lineaer genevektor. | |
ATE99324T1 (de) | Nor-statin und nor-cyclostatin enthaltende polypeptide. |